Literature DB >> 27372

Controlled double-blind trial of camazepam, a new benzodiazepine derivative, versus chlordiazepoxide.

S Carrara, M Mauri, M Guazzelli, C Maggini, P Castrogiovanni.   

Abstract

31 in-patients with anxiety entered at random in a double-blind clinical trial of chlordiazepoxide and camazepam, a benzodiazepine derivative. They were assessed by three different rating scales. Statistical evaluation of the results showed similar psychopharmacological activity of both drugs. It is concluded that camazepam is suitable for treatment of mild and severe anxiety states.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 27372     DOI： 10.1007/BF00644605

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  10 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Camazepam versus diazepam: a double-blind trial on psychoneurotic patients.

Authors:  R Deberdt
Journal:  Curr Ther Res Clin Exp       Date:  1975-01

4.  [Inotropic and chronotropic effects of some benzodiazepines on the guinea-pig atrium].

Authors:  R Ferrini; G Miragoli
Journal:  Boll Soc Ital Biol Sper       Date:  1973-07-15

5.  Carbamate ester latentiation of physiologically active amines.

Authors:  A J Verbiscar; L G Abood
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

6.  [Double-blind trial treatment of anxiety with b 5833].

Authors:  R Cloquette
Journal:  Acta Psychiatr Belg       Date:  1974-05

7.  Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.

Authors:  R Ferrini; G Miragoli; B Taccardi
Journal:  Arzneimittelforschung       Date:  1974-12

8.  [Comparative double-blind clinical trial of SB 5833 and temazapam].

Authors:  V Porta; G Jann; G B Delzanno
Journal:  Brux Med       Date:  1974-11

9.  Effect of camazepam (SB-5833), a new antianxious drug, on cardiac contractility and coronary hemodynamics.

Authors:  L Merlo; V Noseda; R Ferrini; G Miragoli; G Marchetti
Journal:  Arzneimittelforschung       Date:  1974-11

10.  A preliminary double-blind study with SB 5833 (camazepam), a new benzodiazepine derivative.

Authors:  M Cesa-Bianchi; P Ghirardi; F Ravaccia
Journal:  Arzneimittelforschung       Date:  1974-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.